Suchergebnisse - "K2T6HJX3I3"

PubPharm (193)

1

Synergistic effect of adavosertib and fimepinostat on acute myeloid leukemia cells by enhancing the induction of DNA damage

enthalten in: Investigational new drugs | 2024

von Wang, Y. | Lin, X. | Wang, Y. | +1

2

Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies : Arm C of the AcSé-ESMART Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Gatz, S. | Harttrampf, A. | Brard, C. | +20

3

AZD1775 and anti-PD-1 antibody synergistically sensitize hepatoma to radiotherapy

enthalten in: Chinese medical journal | 2024

von Yin, Y. | Wang, J. | Yi, J. | +4

4

Adavosertib and beyond : Biomarkers, drug combination and toxicity of WEE1 inhibitors

enthalten in: Critical reviews in oncology/hematology | 2024

von Zhang, C. | Peng, K. | Liu, Q. | +2

5

Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von DiPeri, T. | Evans, K. | Raso, M. | +13

CommentIn: Clin Cancer Res. 2023 Nov 1;29(21):4317-4319. - PMID 37656059

6

Wee1 inhibition by MK1775 potentiates gemcitabine through accumulated replication stress leading to apoptosis in biliary tract cancer

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Chen, C. | Yeh, C. | Pan, Y. | +4

7

WEE1 kinase inhibitor MK-1775 sensitizes oral tongue squamous cell carcinoma cells to radiation irrespective of TP53 status

enthalten in: Oral diseases | 2023

von Al-Jamaei, A. | de Visscher, J. | Subramanyam, V. | +4

8

Synergistic interactions of cytarabine-adavosertib in leukemic cell lines proliferation and metabolomic endpoints

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Rodríguez-Vázquez, G. | Diaz-Quiñones, A. | Chorna, N. | +4

9

Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth

enthalten in: Cell death & disease | 2023

von Della Monica, R. | Buonaiuto, M. | Cuomo, M. | +20

10

Phase I study to assess the effect of adavosertib (AZD1775) on the pharmacokinetics of substrates of CYP1A2, CYP2C19, and CYP3A in patients with advanced solid tumors

enthalten in: Cancer chemotherapy and pharmacology | 2023

von Någård, M. | Ah-See, M. | Strauss, J. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]